Cash as at 31st January $12.1 millionCash as at 4th March $4.2 millionUsage for 32 days $7.9 million ($246K/day)Cash will run out on 21st March at 10.30am
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%